Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BITS7201A in Healthy Volunteers and Mild Atopic Asthma
NCT02748642Phase 1Completed
- Sponsor
- Genentech
- Start
- Apr 2016
- Primary completion
- Jun 2017
- Modality
- Antibody Conjugates, Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of BITS7201A (11 arms), sponsored by Genentech. Primary endpoints: Percentage of Participants with Adverse Events at 12 months and Number of Participants with Anti-Therapeutic Antibodies to BITS7201A at 12 months. Started Apr 2016; status: completed.
02
Drugs
BITS7201A
Beyond the preview
Go deeper on NCT02748642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02748642.